Blood and Urine Sample Collection From Healthy Volunteers
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
The aim of the study is to obtain peripheral venous blood samples and a urine sample from 100 healthy volunteers on one day at three different times of the day, to serve as a healthy control group for cross-cohort comparisons.
With the help of the urine and blood samples obtained in this context, a cohort of a healthy collective is to be established for further research purposes.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Hamburg, Germany, 20251
- CTC North
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy male and female subjects aged 40-70 years.
- Caucasian
- Non-smokers or ex-smokers
- Body Mass Index (BMI): ≥18.5 and ≤32 kg/m2
- Presence of a negative SARS-CoV-2 PCR test.
Exclusion Criteria:
- Complaints that may indicate the presence of an infection, including Covid-19.
- Pathological alcohol consumption.
- Positive alcohol breath test at the preliminary examination.
- Alcohol consumption within the last 24 hours before the start of sampling.
- History of drug dependence.
- Positive urine drug test during the preliminary examination.
- Clinically significant acute or chronic disease. In particular, chronic inflammation, rheumatological and other autoimmune diseases, diabetes and other metabolic diseases.
- Indications in the medical history or during the medical examination that may jeopardize the safety of the study participant by participating in the study.
- History of relevant clinically significant cardiovascular disorders or clinically relevant hyper- or hypotension or clinically relevant brady- or tachycardia at screening as assessed by an investigator.
- Heart rate <45/min after 5 minutes in a quiet sitting position.
- Heart rate >100/min after 5 minutes in a quiet sitting position.
- Systolic blood pressure of > 170 mmHg or < 90 mmHg.
- Diastolic blood pressure of > 95 mmHg and/or < 60 mmHg.
- Regular use of prescription medication within 3 months prior to inclusion in the research project.
- Use of non-prescription medications within 3 days prior to inclusion in the research project.
- Presence of clinically significant food intolerance and/or food allergy as assessed by the investigator.
- Medically relevant previous operations.
- Condition following radio- or chemotherapy.
- History of oncological diseases.
- Blood and/or plasma donation within the last 30 days prior to sample collection.
- Pregnant or nursing female.
- Employees of study site.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collection of blood samples from healthy volunteers to serve as a healthy control group.
Time Frame: 1 day
|
There are no primary endpoints planned; endpoints will be specified in the individual research projects that will utilize the blood samples as a control group.
|
1 day
|
|
Collection of urine samples from healthy volunteers to serve as a healthy control group.
Time Frame: 1 day
|
There are no primary endpoints planned; endpoints will be specified in the individual research projects that will utilize the urine samples as a control group.
|
1 day
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Hanna Peradziryi, Hanna.Peradziryi@evotec.com
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- EVT_CTC_01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.